Ki-Hwan Kwon
Directeur Général chez Exollence Co., Ltd.
Fortune : 849 157 $ au 30/04/2024
Provenance du réseau au premier degré de Ki-Hwan Kwon
Entité | Type d'entité | Industrie | |
---|---|---|---|
Exollence Co., Ltd.
Exollence Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Exollence Co., Ltd. operates as a South Korean drug delivery platform technology company. The company is based in Seoul, South Korea. The company was founded in 2019. The CEO is Ki-Hwan Kwon.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ki-Hwan Kwon via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Seoul National University | College/University | Graduate Degree | |
I-SENS, INC. | Medical Specialties | Director/Board Member | |
Nano-Ditech Corp.
Nano-Ditech Corp. Medical SpecialtiesHealth Technology Nano-Ditech Corp. develops immuno-diagnostic products. It serves the point-of-care marketplace including medical professionals, physicians, clinical laboratories and hospitals. The firm focuses on rapid POCT immunoassays for the detection of drugs of abuse and cardiac markers in the emergency department. The company was founded in 2002 and is headquartered in Cranbury, NJ. | Medical Specialties | Director/Board Member |
Statistiques
Internationale
Corée du Sud | 3 |
Etats-Unis | 2 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Opérationnelle
Director/Board Member | 3 |
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Relations les plus connectées
Insiders | |
---|---|
Gang-See Lee | 4 |
- Bourse
- Insiders
- Ki-Hwan Kwon
- Connexions Sociétés